GE Healthcare has partnered with Sweden-based Karolinska University Hospital, to help improve the efficiency of the care pathway for pelvic cancer patients and reduce unwarranted clinical variation.

Under the deal, GE Healthcare will offer consultancy services, tools for healthcare analytics and a PET/CT imaging platform to the hospital.

The contract is for a period of 14 years, and an option has been provided to extend it for further six.

GE Healthcare Northern Europe general manager Karl Blight said: "Currently, each care pathway for each pelvic cancer is being managed separately by specialties such as surgeons, urologists, gynaecologists, but they all converge at various points in the pathway.

"This represents an important opportunity for knowledge transfer between specialties and delivering improvements in value-based healthcare across multiple care pathways."

"GE Healthcare will offer consultancy services, tools for healthcare analytics and a PET/CT imaging platform to the hospital."

The deal will allow the hospital access with a Caradigm intelligence platform (CIP) from Caradigm, a joint venture of GE Healthcare and Microsoft.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

This platform will be used to combine data, including clinical patient data, financial and operational data, from different systems, which will help in better clinical decision support, analysis and prediction.

According to GE, the PET/CT technology will be used in the pelvic cancer patient pathway, ranging from diagnosis to disease staging and treatment monitoring.

Throughout the whole contract period, GE will continue to update the imaging platform with advanced technology.

Image: Karolinska Solna – Hospital in Stockholm. Photo: courtesy of Holger.Ellgaard.